Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients
NCT02918695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-05-04
Summary
The purpose of this study is to compare clinical judgment and comprehensive geriatric assessment as screening tools for optimization of treatment for newly diagnosed elderly multiple myeloma patients.
Conditions
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Michel Delforge, MD PhD · UZ Leuven Gasthuisberg
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-07
- Primary Completion
- 2021-02-02
- Completion
- 2021-02-02
Countries
- Belgium
Study Locations
More Related Trials
-
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
NCT00416208 ·Status: COMPLETED ·Phase: PHASE3
-
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
NCT06365060 ·Status: RECRUITING
-
Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma
NCT00367185 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Home Administration of Carfilzomib
NCT04621955 ·Status: WITHDRAWN
-
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
NCT06212323 ·Status: RECRUITING
-
Telemonitoring Among Patients With Multiple Myeloma
NCT05964270 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
NCT00445068 ·Status: TERMINATED ·Phase: PHASE2
-
Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
NCT02063113 ·Status: TERMINATED ·Phase: NA
-
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
NCT02308280 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Myeloma Minimal Residual Disease
NCT02627261 ·Status: COMPLETED
-
Maintenance Therapy Using Lenalidomide in Myeloma
NCT00430365 ·Status: COMPLETED ·Phase: PHASE3
-
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
NCT01453088 ·Status: TERMINATED ·Phase: PHASE2
-
Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients
NCT04379817 ·Status: COMPLETED ·Phase: PHASE2
-
Precision Medicine Study
NCT06338150 ·Status: RECRUITING
-
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
NCT02997813 ·Status: COMPLETED
-
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
NCT04999085 ·Status: COMPLETED ·Phase: NA
-
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
NCT05355987 ·Status: COMPLETED ·Phase: NA
-
Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
NCT00891384 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of High Dose Simvastatine on Multiple Myeloma
NCT00281476 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PRospective Multiple Myeloma Impact Study
NCT02911571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.
NCT04144387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective Survey of Re-treatment With Bortezomib
NCT01524445 ·Status: COMPLETED
-
A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
NCT00416273 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Myeloma and Exercise
NCT01809717 ·Status: COMPLETED ·Phase: NA
-
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.
NCT02164955 ·Status: COMPLETED